Jamaica will decriminalize pot possession and Bermuda is thinking about it, legalization initiatives in Alaska and Oregon get big bucks donations, medical marijuana reform is moving in the DC city council, and more. Let's get to it:
[image:1 align:right]MPP Gives Alaska Initiative Campaign Big Cash Contribution. The Marijuana Policy Project, which is backing the Alaska legalization initiative, has just kicked in another $140,000. That's the second largest contribution to the campaign yet (the biggest, also from MPP, was $210,000), and pushes its total contributions to over half a million dollars. The organized opposition -- Big Marijuana, Big Mistake, Vote No on 2 -- has, on the other hand, raised only $31,000, most of it in a single donation by an Alaska Native village corporation.
Peter Lewis Family Gives Oregon Initiative Campaign Big Cash Contribution. A PAC controlled by heirs of Progressive Insurance founder and drug reform funder Peter Lewis has donated $250,000 to the New Approach Oregon legalization initiative. Lewis had donated $96,000 before his death last fall, and there were fears his death could end his reform largesse, but his family is carrying on. The group has raised more than $900,000 overall.
SurveyUSA Oregon Poll Has 51% for Legalization. A new SurveyUSA poll in Oregon has 51% supporting marijuana legalization, with 41% opposed, and 8% undecided. The poll comes as three legalization initiatives are in the final weeks of signature-gathering to put the issue on the November ballot. Initiative organizers are not going to breathe easy with numbers like these, though; the conventional wisdom is that initiatives want to be polling at 60% or above before the campaign begins in earnest. Click on the link for demographic and methodological details.
DC Council Moves Toward Approving Expanded Medical Marijuana Access. The District of Columbia city council moved ahead yesterday with plans to expand access to medical marijuana. In a joint session of the Health and Judiciary and Public Safety committees, the council gave preliminary approval to two bills. Bill 20-766, cosponsored by every member of the council, would repeal the qualifying conditions list and allow physicians to recommend marijuana to any patient they think marijuana would benefit. Bill 20-678, will increase the number of plants a cultivation center could possess from 95 to 500, better ensuring that patient need is met.
Feds Warn Casinos to Not Take Bets Made With Marijuana Money. Federal regulators addressing a banking secrecy conference in Las Vegas yesterday warned casinos they can't accept bets from people working in the marijuana industry unless the casinos undertake rigorous background checks and allow the federal government to monitor the bets. That's because casinos are subject to the same financial reporting requirements as financial institutions. It's a lengthy report; click on the link to read it all.
Fair Sentencing Act Gets Another Cosponsor. Add Rep. David Joyce (R-OH) to the list of cosponsors of the federal Fair Sentencing Act of 2013. He signed on yesterday. That makes 24 Democrats and 14 Republicans. The bill is before the House Judiciary Committee. Clicking on the link will take you to the bill.
Virginia Sheriff's Office Makes Mass Drug Bust… Again… and Again. The Amherst County Sheriff's Office announced yesterday that a county grand jury had indicted 68 people on drug charges after a months-long investigation by the department. It's the third mass bust since 2010's Operation Silent Night and 2012's Operation Avalanche. The sheriff's office seems to understand--at least on some level--the futility of such operations: "It stops these folks from selling drugs [but] as soon as you remove these folks, someone else takes their place. It's a never-ending cycle we're working on," a spokesman said.
Jamaica Will Decriminalize Marijuana Possession. Jamaica will decriminalize the possession of small amounts of marijuana, the government announced yesterday. It will also allow possession for some medical and scientific purposes. And it will allow possession for religious purposes. Justice Minister Mark Golding said that the cabinet is supporting a proposal to decriminalize the possession of to two ounces of the ganja. Under the proposal, those caught with marijuana could be subjected to fines, but not criminal charges.
Bermuda's Attorney General Says Government Should Consider Marijuana Decriminalization. As the Bermudan government mulls marijuana reform, new Attorney General Trevor Moniz has come out for decriminalization. Moniz would prefer "a system where if you get caught with a small amount of marijuana, you don't go to court and you wouldn't have any criminal record," he said. "In New York and the UK., they have a caution only for a first offence, which may need to be broadened. I'm in favor of small steps, incremental steps, rather than a big leap," he added.
Barcelona Bans New Cannabis Clubs for a Year. Citing a proliferation of private cannabis clubs and a lack of regulation, the Barcelona city council announced today it was instituting a moratorium on new clubs for one year. The crackdown comes just days after a club was closed for illegal sales. The clubs allow members to grow and consume their own cannabis, but they aren't supposed to sell the stuff to outsiders. The clubs have been attracting cannabis tourists from around the world.
Conflict in Turkish Municipality Tied to Marijuana Crop. Three weeks of violent protests in the municipality of Lice in Diyarbakir Province, where Kurds predominate, are linked to the looming marijuana harvest, some of the profits from which are destined for the Kurdistan Workers Party (PKK), according to this report. Violent incidents have been ongoing since demonstrators attacked a security forces outpost with homemade bombs and Molotov cocktails, and soldiers opened fire, killing the nephew of a "notorious trafficker."
[Full disclosure: I researched and wrote most of this report and was paid by DPA to do so.]
In a report released this week, the Drug Policy Alliance (DPA) and the Multidisciplinary Association for Psychedelic Studies (MAPS) reveal a decades-long pattern of the DEA ignoring scientific evidence and systematically obstructing medical research that could lead to the rescheduling of marijuana.
[image:1 align:left]The report comes just days after the House issued a stinging rebuke to the DEA by approving a bipartisan measure that bars the use of federal taxpayer dollars for the DEA to undermine medical marijuana in states where it is legal. The House also approved measures stripping the DEA's ability to interfere with hemp production in states where it is legal.
While the report found that the DEA tends to move with excruciating slowness when confronted with evidence that confounds its ideological predispositions, the agency is able and willing to move at lightning speed to criminalize more drugs or schedule them more restrictively.
The report, The DEA: Four Decades of Impeding and Rejecting Science, uses a number of case studies to unveil DEA practices to maintain the existing, scientifically unsupported drug scheduling system. They include:
Failing to act in a timely fashion. The DEA took 16 years to issue a final decision rejecting the first marijuana rescheduling petition, five years for the second, and nine years for the third. In two of the three cases, it took multiple lawsuits to force the agency to act.
Overruling DEA Administrative Law Judges. DEA Administrative Law Judges are government officials charged with evaluating the evidence on rescheduling and other matters before the DEA and making recommendations based on that evidence to the DEA Administrator. In the cases of the scheduling of marijuana and MDMA, the judges determined that that they should be placed in Schedule II instead of Schedule I, where they would be regulated by the Food and Drug Administration (FDA) as prescription medicines, but still retain criminal sanctions for non-medical uses. However, agency administrators overruled their Administrative Law Judges' recommendations, substituting their own judgments and ignoring scientific evidence. The current DEA head, Michelle Leonhart, also rejected a DEA Administrative Law Judge ruling that the DEA end its unique and unjustifiable monopoly on the supply of research-grade marijuana available for federally approved research.
Creating a regulatory Catch-22. The DEA has argued for decades that there is not sufficient evidence to support rescheduling marijuana or the medical use of marijuana. At the same time, it has -- along with the National Institute on Drug Abuse -- acted in a manner intended to systematically impede scientific research. Through the use of such tactics, the DEA has repeatedly and consistently demonstrated that it is more interested in maintaining existing drug laws than in making important drug control decisions based on scientific evidence.
The report makes two central recommendations: 1) that the responsibility for determining drug classifications and other health determinations should be completely removed from DEA and transferred to another agency, perhaps even a non-governmental entity such as the National Academy of Sciences, and 2) that the DEA should be ordered to end the federal government's unjustifiable monopoly on the supply of research-grade marijuana available for federally approved research. No other drug is available from only a single governmental source for research purposes.
[image:2 align:right caption:true]"The DEA abuses its discretionary powers over scheduling, making it incredibly difficult for researchers to obtain marijuana for research purposes," said DPA executive director Ethan Nadelmann during a Wednesday teleconference to announce the report. "Our recommendations call for taking the power over drug scheduling away from the DEA. It is essentially a police and propaganda agency. This authority would be better handled by another government agency in the health realm, or a truly independent agency, like the National Academy of Sciences," he said.
"The DEA and Ms. [Michele] Leonhart have constantly been opposing any science that would change her mindset and opinion, which was apparently created around 1937," said Rep. Steven Cohen (D-TN), referencing the year federal marijuana prohibition began. "She is totally against marijuana, she will not admit that it is not as harmful as heroin or cocaine, and she is on a war on drugs."
Cohen was the author of another successful amendment that spanked the DEA. His successful amendment redirected $5 million in DEA funding to instead be used to help reduce a back log of rape kits that need testing. He said he was happy to be part of the congressional effort to restrict the agency.
"I was thrilled to be part of that coalition," Cohen said. "Those amendments to the appropriations bill were a great victory. We've been voting on this since 2007, and we always had about 165 Democrats on board, and a few more this time. Rep. Dana Rohrabacher (R-CA) did a great job getting Republicans on board; he got some of the younger, more libertarian members and members who know people marijuana has helped."
"The DEA has opposed efforts to reform federal scheduling policy to acknowledge that marijuana has medical purposes," said Dr. Carl Hart, a Columbia University neuroscientist. "As someone who has studied marijuana, this concerns me. That the DEA has not rescheduled marijuana seems to go against all the scientific evidence and against a society that uses empirical evidence."
MAPS executive director Rick Doblin said his organization, acting as a non-profit pharmaceutical company, had been trying for 22 years to develop Schedule I drugs like marijuana into FDA-approved medications, but that the DEA and other federal agencies had made that impossible.
[image:3 align:left caption:true]"Twenty-two years later, I've been unable to start a single, privately-funded study, and the main reason is the DEA's refusal to open the door," he said. "The National Institute on Drug Abuse (NIDA) has a DEA-protected monopoly on the production of marijuana for research, and although we've had two protocols approved by the FDA and review boards, we have been unable to obtain marijuana. We tried for seven years to buy 10 grams of marijuana for vaporizer studies; we were unable to do that. We've been in litigation with the DEA for 12 years and lost on the grounds that NIDA had an adequate supply."
One study -- of marijuana's efficacy in treating PTSD -- has been approved, Doblin said, but even there, the process has been painfully slow.
"We started trying to get that approved four years ago," he said. "We finally got approval from NIDA in March of this year, but they say they won't have the marijuana we need until January 2015."
For Doblin, it's all about ending NIDA's monopoly on marijuana for research purposes.
"DEA is protecting the NIDA monopoly, which should be ended," he said. "That's the action item we should be doing right now."
The DEA has been politically bulletproof since it was created by the Nixon White House in 1973. But that is changing, DPA national affairs director Bill Piper argued.
"When you look at Congress, with so many members driven by frustration that the DEA is blocking research and preventing medical marijuana from moving forward, that's a big reason the House voted for those amendments," he said. "The DEA has said that marijuana is not approved by the FDA, but Congress has figured out that DEA is blocking the necessary trials from moving forward. The more the DEA obstructs the research, the more support there is for changing federal law and cutting the DEA's authority. The days when the DEA can quietly block this stuff are over; they will pay a price if they stand in the way of reform."
Marijuana reform is exciting some third-party activity, New York's medical marijuana bill is still alive amidst ongoing last-minute negotiations, the New York Senate has passed a package of anti-opiate bills that will bring on more drug war, a high-level commission calls for radical drug policy changes in West Africa, and more. Let's get to it:
[image:1 align:left caption:true]Marijuana Policy
Minnesota Independence Party Runs on Legalization Platform. The Independence Party of Minnesota, a fiscally conservative and socially liberal state party, is making marijuana legalization a key part of its 2014 platform. The party, which is fielding candidates in a number of statewide and legislative races, is descended from the Jesse Ventura-era Reform Party. Its gubernatorial candidate got 12% of the vote in the 2010 election.
New Jersey Democrats Try to Kick NJ Weedman Off Ballot. Ed Forchion, better known as the NJ Weedman, is running for a congressional seat on the Legalize Marijuana Party ticket, but the state Democratic Party issued a last-minute (or past the last minute) challenge to his candidacy Monday afternoon. The Democrats claim he is one signature short of qualifying and that he registered to vote last month in California, where he sometimes resides. NJ Weedman says he will fight the challenge.
New York Medical Marijuana Bill Still Alive; Talks Underway. Last minute negotiations to pass the Compassionate Care Act continued in Albany today. The measure was transferred out of the Senate Finance Committee, where the committee chair said yesterday he would not allow a vote, to the Senate Rules Committee. Bill sponsor Sen. Diane Savino (D-Staten Island) said she is in talks with legislative leaders and Gov. Andrew Cuomo's (D) office to keep the bill alive. Cuomo said earlier today that he still has "serious questions" about the bill. Stay tuned.
South Carolina Democrats Overwhelmingly Favor Medical Marijuana in Non-Binding Primary Question. South Carolina Democrats voting in the party primary Tuesday supported a non-binding question about allowing for medical marijuana use by a margin of three-to-one. The state passed a limited CBD medical marijuana bill this year, but that will only help a small number of patients.
New York Senate Passes Package of Heroin Bills; Would Intensify Drug War. The state Senate earlier this week passed a massive package of bills aimed at dealing with increased levels of heroin and other opiate use. While the package includes prevention and harm reduction measures, such as increasing access to the overdose reversal drug naloxone, other bills in the package seek to limit access to prescription opiates for acute pain, and the majority of the 23-bill package are law enforcement measures that aim to take the state back in the direction of the draconian Rockefeller drug laws of the 1970s. Read the complete list of bills passed here. Whether any of these will become law remains to be seen; the session ends next week.
West Africa Needs to Consider Drug Decriminalization, Report Says. The West Africa Commission on Drugs, headed by former UN Secretary General Kofi Annan, issued a report today calling for radical policy changes, including drug decriminalization, to reduce regional instability in West Africa exacerbated by the illicit trade in drugs. Otherwise, the region faces becoming "a new front line in the failed 'war on drugs,'" the report says. It also calls for drugs to be treated primarily as a public health issue. The report is Not Just in Transit: Drugs, the State, and Society in West Africa.
Spain to Start Including Illicit Drug Trade in GDP. Spanish officials said today they will begin including estimated revenues from the drug trade, as well as prostitution, in calculating the country's Gross Domestic Product. Other European countries are doing the same as part of new European Union requirements that they must state percentages of GDP derived from illicit activities.
Peru Coca Output Declined Last Year, Prices Soared Amidst Eradication Efforts. The UN Office on Drugs and Crime (UNODC) reported Wednesday that, under the pressure of eradication campaigns, coca leaf production declined 18% last year, but that prices jumped nearly 50%, to more than $1300 a kilogram. The UNODC noted the changes in its annual Peruvian coca survey. Cultivation fell last year after expanding for the seven previous years. Peru is either the world's number one or number two coca producer; we'll have to see what UNODC says about Colombian production later this year. Bolivia is number three.
Mexico Awaiting DNA Test Results to Confirm Death of Sinaloa Cartel Leader "El Azul" Esparragoza. Mexican officials are waiting for DNA test results that would confirm the death by natural causes of Sinaloa cartel leader Juan Jose "El Azul" Esparragoza, which was first reported by the Sinaloa news weekly RioDoce on Sunday. Family members have reportedly confirmed his death, but the government is still waiting to make it official.
(This article was published by StoptheDrugWar.org's lobbying arm, the Drug Reform Coordination Network, which also shares the cost of maintaining this web site. DRCNet Foundation takes no positions on candidates for public office, in compliance with section 501(c)(3) of the Internal Revenue Code, and does not pay for reporting that could be interpreted or misinterpreted as doing so.)